Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-002050
Filing Date
2025-01-08
Accepted
2025-01-08 16:30:38
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252665-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm252665-2_4seq1.xml 4 6465
  Complete submission text file 0001104659-25-002050.txt   8154
Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
DELUCCIA ROBERT J (Reporting) CIK: 0001127423 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40536 | Film No.: 25518918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)